RESEARCH TRIANGLE PARK, N.C. — Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the completion of its acquisition by affiliates of Altaris, LLC (“Altaris”), an investment firm focused exclusively on the healthcare industry. The transaction was originally announced […]
New IPA Investigator lets researchers ask biological questions in natural language and examine the scientific evidence behind the results New QIAGEN Discovery Platform extends AI into drug discovery workflows QIAGEN builds on more than 25 years of biomedical knowledge, with QDI tools used by around 150,000 users VENLO, Netherlands & GERMANTOWN, Md. — QIAGEN N.V. […]
Collaboration brings EpiSign’s comprehensive DNA methylation episignature analysis together with the Geneyx genomic and multi-omics analysis platform LONDON, ON and HERZLIYA, Israel — EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis for rare-disease interpretation. The collaboration combines EpiSign’s expertise in DNA methylation episignature analysis […]
New software extends automated analysis of more than 300 episignature disorders beyond methylation microarrays to Illumina 5-base, PacBio HiFi and Oxford Nanopore sequencing data LONDON, ONTARIO — EpiSign Inc. today announced the launch of EpiSign METRIC 5-base, extending its comprehensive and automated episignature analysis framework beyond methylation microarrays to sequencing-derived DNA methylation data. EpiSign METRIC […]
SAN FRANCISCO — Edison Scientific is pleased to announce that it has signed a subscription agreement with Springer Nature that will bring trusted licensed content from 60 specialist journals across Springer Nature’s Nature Portfolio into Edison’s AI scientist, Kosmos. As research output continues to grow, important findings can be difficult to identify and sometimes may […]
Seed financing led by Kickstart will accelerate causal genomics platform development and the company’s first commercial Atlas. Genomic AI needs more than DNA sequences. It needs to learn from what genetic changes actually do in human cells” — Ryan T. Gill, Co-Founder and CEO, Codebreaker Labs BOULDER, CO, UNITED STATES — Codebreaker Labs today announced the […]
Model-agnostic platform enables researchers to build and deploy custom AI scientist agents within Federated Trusted Research Environments London, UK — Lifebit, a leading provider of secure biomedical data platforms and Trusted Research Environments (TREs), has announced the launch of AI Scientist Studio at HumanX Amsterdam. The new platform enables researchers to build and deploy custom AI […]
Agency will use the software platform to support modern cosmetic safety assessment through integrated exposure and toxicity modeling. RESEARCH TRIANGLE PARK, N.C. — Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that the U.S. Food and Drug Administration’s […]
Researchers provided biological expertise and feedback that helped guide the development of a new AI-powered resource released today. For the first time, scientists can explore a comprehensive map of more than 9 billion possible single-letter DNA changes KEY HIGHLIGHTS Developed over several years, AlphaGenome Atlas is a one-petabyte dataset containing molecular-effect predictions for more than […]
Certified and integrated ecosystem within BC Mosaic helps healthcare and life sciences teams accelerate research and innovation by bringing specialized tools into BC Platforms’ industry-leading trusted research environment BC Platforms today announced the launch of the BC Mosaic App Store, a certified ecosystem of specialized analytical and research applications. Through the BC Mosaic App Store, […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
